[Activity Report] The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (November 7, 2020)
date : 12/1/2020
Tags: AMR
The AMR Consortium (Secretariat: AMR Alliance Japan) of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) shared key points of its policy recommendations calling for the creation of a pull incentive to encourage antimicrobial R&D at the 7th NIKKEI FT Communicable Diseases Conference.
Over the past year, the AMR Consortium has debated schemes that would be able to incentivize antimicrobial R&D in the future.
At the NIKKEI FT Communicable Diseases Conference, the Consortium shared key points from policy recommendations that were developed based on that debate, and considered points to be discussed further in the future.
In light of the situation with novel coronavirus, this conference was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Saturday, November 11, 2020
Program: Agenda4- Performance of PPP from the Conference and Future Issues
■Discussion
Participants from AMR Consortium of the Nikkei Asia Africa Conference on Communicable Diseases –Asia Africa Medical Innovation Consortium (AMIC) (alphabetical order by last name) :
Hajime Inoue (Deputy Director General, Office for Novel Coronavirus Disease Control, Cabinet Secretariat)
Shoji Miyagawa (Director, Division of Basic Medical Research, Department of Basic Medical Research, the Japan Agency for Medical Research and Development)
Takeo Morooka (Executive Officer, Head of Health Policy and Corporate Support, MSD K.K.)
Hiroyuki Noda (Councilor, Coordination Office of Measures on Emerging Infectious Diseases, Office of Pandemic Influenza and New Infectious Diseases Preparedness and Response, Cabinet Secretariat)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Jean-Pierre Paccaud(Director of Business Development and Corporate Strategy, Global Antibiotic R&D Partnership Foundation (GARDP))
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases/President, The Japanese Society for Clinical Microbiology/Professor, Department of Microbiology and Infectious Diseases, Toho University)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Yasuhide Yamada (Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat, Government of Japan Executive Officer/Executive Officer, SHIMIZU CORPORATION)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
Top Research & Recommendations Posts
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)